4.7 Article

IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 218, 期 6, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20200303

关键词

-

资金

  1. Swiss National Science Foundation [31003A_176170, 314730_172790, 31003A_182464]
  2. Hartmann Muller Foundation [2038]
  3. National Institutes of Health [U19AI117873, P01AI097092]
  4. Center for Research on Influenza Pathogenesis [HHSN272201400008C]
  5. Swiss National Science Foundation (SNF) [314730_172790, 31003A_176170] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

The severity of influenza varies greatly in humans, and the IFITM3 gene is a genetic determinant responsible for these differences. IFITM3 blocks cytosolic entry of influenza A virus by competing with viral hemagglutinin incorporation into virions. This inhibition leads to increased sensitivity of IAV to antibody-mediated neutralization and affects infection outcomes.
The disease severity of influenza is highly variable in humans, and one genetic determinant behind these differences is the IFITM3 gene. As an effector of the interferon response, IFITM3 potently blocks cytosolic entry of influenza A virus (IAV). Here, we reveal a novel level of inhibition by IFITM3 in vivo: We show that incorporation of IFITM3 into IAV particles competes with incorporation of viral hemagglutinin (HA). Decreased virion HA levels did not reduce infectivity, suggesting that high HA density on IAV virions may be an antagonistic strategy used by the virus to prevent direct inhibition. However, we found that IFITM3-mediated reduction in HA content sensitizes IAV to antibody-mediated neutralization. Mathematical modeling predicted that this effect decreases and delays peak IAV titers, and we show that, indeed, IFITM3-mediated sensitization of IAV to antibody-mediated neutralization impacts infection outcome in an in vivo mouse model. Overall, our data describe a previously unappreciated interplay between the innate effector IFITM3 and the adaptive immune response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据